Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 393-400

  Gui, G P H ^a   Thomas, P R S ^a,b   Tizard, M L V ^a   Lake, J ^a   Sanderson, J D ^a,c   Hermon Taylor, J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; CLARITHROMYCIN; MACROLIDE; RIFABUTIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN TISSUE; LETHARGY; MALAISE; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CLARITHROMYCIN; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; REMISSION INDUCTION; RIFABUTIN; SERUM ALBUMIN;

EID: 0030906446     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.393     Document Type: Article

References (47)

1. Chiodini, R. J., Van Kruiningen, H. J., Merkal, R. S., Thayer, W. R. & Coutu, J. A. (1984). Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. Journal of Clinical Microbiology 20, 966-71.
2. McFadden, J. J., Butcher, P. D., Chiodini, R. & Hermon-Taylor, J. (1987). Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis as determined by DNA probes that distinguish between mycobacterial species. Journal of Clinical Microbiology 25, 796-801.
3. Gitnick, G., Collins, J., Beaman, B., Brooks, D., Arthur, M., Imaeda, T et al. (1989). Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Digestive Diseases and Sciences 34, 925-32.
4. Thorel, M.-F. (1989). Relationship between Mycobacterium avium, M. paratuberculosis and mycobacteria associated with Crohn's disease. Annales de Recherches Vétérinaires 20, 417-29.
5. Haagsma, J., Mulder, C. J. J., Eger, A. & Tytgat, G. N. J. (1991). Mycobacterium paratuberculosis isolé chez des patients atteints de maladie de Crohn: résultats préliminaires. Acta Endoscopica 21, 255-60.
6. Wall, S., Kunze, Z. M., Saboor, S., Soufleri, J., Seechurn, P., Chiodini, R. et al. (1993). Identification of spheroplast-like agents isolated from tissues of patients with Crohn's disease and control tissues by polymerase chain reaction. Journal of Clinical Microbiology 31, 1241-5.
7. Pavlic, I., Bejckova, L., Koskova, S., Fixa, B., Komarkova, O. & Bedrna, J. (1994). DNA fingerprinting as a tool for epidemiological studies of paratuberculosis in ruminants and Crohn's disease. In Proceedings of the Fourth International Colloquium on Paratuberculosis (Chiodini, R. J., Collins, M. T. & Bassey, E., Eds), pp. 279-89. International Association for Paratuberculosis Inc., Rehoboth, MA.
8. Moss, M. T., Sanderson, J. D., Tizard, M. L., Hermon-Taylor, J., el-Zaatari, F. A., Markesich, D. C. et al. (1992). Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum in long term cultures from Crohn's disease and control tissues. Gut 33, 1209-13.
9. Sanderson, J. D., Moss, M. T., Tizard, M. L. V. & Hermon-Taylor, J. (1992). Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 33, 890-6.
10. Dell'Isola, B., Poyart, C., Goulet, O., Mougenot, J.-F., Sadoun- Journo, E., Brousse, N. et al. (1994). Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease. Journal of Infectious Diseases 169, 449-51.
11. Fidler, H. M., Thurrell, W., Johnson, N. M., Rook, G. A. W. & McFadden, J. J. (1994). Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut 35, 506-10.
12. Lisby, G., Andersen, J., Engbaek, K. & Binder, V. (1994). Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scandinavian Journal of Gastroenterology 29, 923-9.
13. Erasmus, D. L., Victor, T. C., van Eeden, P. J. & van Helden, P. (1995). Mycobacterium paratuberculosis and Crohn's disease. Gut 36, 942.
14. Suenaga, K., Yokoyama, Y., Okazaki, K. & Yamamoto, Y. (1995). Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. American Journal of Gastroenterology 90, 76-80.
15. Mishina, D., Katsel, P., Brown, S. T., Gilberts, E. C. A. M. & Greenstein, R. J. (1996). On the etiology of Crohn's disease. Proceedings of the National Academy of Sciences of the United States of America 93, 9816-20.
16. Chiodini, R. J., Van Kruiningen, H. J. & Merkal, R. S. (1984). Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Veterinarian 74, 218-62.
17. McClure, H. M., Chiodini, R. J., Anderson, D. C., Swenson, R. B., Thayer, W. R. & Coutu, J. A. (1987). Mycobacterium paratuberculosis (infection) in a colony of stumptail macaques (Macaca arctoides). Journal of Infectious Diseases 155, 1011-9.
18. Millar, D., Ford, J., Sanderson, J., Withey, S., Tizard, M., Doran, T. et al. (1996). IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Applied and Environmental Microbiology 62, 3446-52.
19. Picciotto, A., Gesu, G. P., Schito, G. C., Testa, R., Varagona, G. & Celle, G. (1988). Antimycobacterial chemotherapy in two cases of inflammatory bowel disease. Lancet i, 536-7.
20. Warren, J. B., Rees, H. C. & Cox, T. M. (1986). Remission of Crohn's disease with tuberculosis chemotherapy. New England Journal of Medicine 314, 182.
21. Shaffer, J. L., Hughes, S., Linaker, B. D., Baker, R. D. & Turnberg, L. A. (1984). Controlled trial of rifampicin and ethambutol in Crohn's disease. Gut 25, 203-5.
22. Afdhal, N. H., Long, A., Lennon, J., Crowe, J. & O'Donoghue, D. P. (1991). Controlled trial of antimycobacterial therapy in Crohn's disease: clofazimine versus placebo. Digestive Diseases and Sciences 36, 449-53.
23. Swift, G. L., Srivastava, E. D., Stone, R., Pullan, R. D., Newcombe, R. G., Rhodes, J. et al. (1994). Controlled trial of antituberculous chemotherapy for two years in Crohn's disease. Gut 35, 363-8.
24. Gangadharam, P. R., Perumal, V. K., Jairam, B. T., Rao, P. N., Nguyen, A. K., Farhi, D. C. et al. (1987). Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections. American Review of Respiratory Diseases 136, 329-33.
25. Panteix, G., Guillaumond, B., Harf, R., Desbos, A., Sapin, V., Leclercq, M. et al. (1993). In-vitro concentration of azithromycin in human phagocytic cells. Journal of Antimicrobial Chemotherapy 31, Suppl. E, 1-4.
26. Luna-Herrera, J., Reddy, M. V. & Gangadharam, P. R. (1995). In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli. Journal of Antimicrobial Chemotherapy 36, 355-63.
27. Onyeji, C. O., Nightingale, C. H., Tessier, P. R., Nicolau, D. P. & Bow, L. M. (1995). Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intra-macrophage Mycobacterium avium-Mycobacterium intracellulae. Journal of infectious Diseases 172, 810-6.
28. Rastogi, N., Goh, K. S. & Labrousse, V. (1992). Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. Antimicrobial Agents and Chemotherapy 36, 2843-6.
29. Harvey, R. F. & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet i, 514.
30. Hampson, S. J., Parker, M. C., Saverymuttu, S. H., Joseph, A. E. A., McFadden, J. J. P. & Hermon-Taylor, J. (1989). Quadruple antimycobacterial chemotherapy in Crohn's disease: results at 9 months of a pilot study in 20 patients. Alimentary Pharmacology and Therapeutics 3, 343-52.
31. Prantera, C., Kohn, A., Mangiarotti, R., Andreoli, A. & Luzi, C. (1994). Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. American Journal of Gastroenterology 89, 513-8.
32. Dautzenberg, B., Truffot, C., Legris, S., Meyohas, M. C., Berlie, H. C., Mercat A. et al. (1991). Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. American Review of Respiratory Disease 144, 564-9.
33. Young, L. S., Wivlott, L., Wu, M., Kolonoski, P., Bolan, R. & Inderlied, C. B. (1991). Azithromycin for treatment for Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 338, 1107-9.
34. Nightingale, S. D., Cameron, D. W., Gordin, F. M., Sullam, P. M., Cohn, D. L., Chaisson, R. E. et al. (1993). Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. New England Journal of Medicine 329, 828-33.
35. Anand, R., Moore, J. L., Curran, J. W. & Srinivasan, A. (1988). Interaction between rifabutin and human immunodeficiency virus type 1 : inhibition of replication cytopathic effect, and reverse transcriptase in vitro. Antimicrobial Agents and Chemotherapy 32, 684-8.
36. Graham, D. Y., AI-Assi, M. T. & Robinson, M. (1995). Prolonged remission in Crohn's disease following therapy for Mycobacterium tuberculosis infection. Gastroenterology 108, Suppl. A826.
37. Mor, N., Vanderkolk, J., Mezo, N. & Heifets, L. (1994). Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. Antimicrobial Agents and Chemotherapy 38, 2738-42.
38. Fattorini, L., Li, B., Piersimoni, C., Tortoli, E., Xiao, Y., Santoro, C. et al. (1995). In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. Antimicrobial Agents and Chemotherapy 39, 680-5.
39. Fraschini, F., Scaglione, F., Pintucci, G., Maccarinelli, G., Dugnani, S. & Demartini, G. (1991). The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil, and lung in humans. Journal of Antimicrobial Chemotherapy 27, Suppl. A, 61-5.
40. Bermudez, L. E., Martinelli, J., Petrofsky, M., Kolonoski, P. & Young, L. S. (1994). Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. Journal of Infectious Diseases 169, 575-80.
41. Young, L. S., Bermudez, L. E., Wu, M. & Inderlied, C. B. (1995). Potential role of roxithromycin against the Mycobacterium avium complex. Infection 23, Suppl. 1, S28-32.
42. Hodgson, H. J. F. & Mazlam, M. Z. (1991). Review article: assessment of drug therapy in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 5, 555-84.
43. Modigliani, R., Mary, J. Y., Simon, J. F., Cortot, A., Soule, J. C., Gendre, J. P. et al. (1990). Clinical, biological and endoscopic picture of attacks of Crohn's disease. Gastroenterology 98, 811-8.
44. Olaison, G., Sjodahl, R. & Tagesson, C. (1990). Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation. Gut 31, 325-8.
45. Weldon, M. J., Lowe, C., Joseph, A. E. A. & Maxwell, J. D. (1996). Review article: quantitative leucocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy. Alimentary Pharmacology and Therapeutics 10, 123-32.
46. Millar, D. S., Withey, S. J., Tizard, M. L., Ford, J. G. & Hermon-Taylor, J. (1995). Solid-phase hybridization capture of low-abundance target DNA sequences: application to the polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp. siivaticum. Analytical Biochemistry 226, 325-30.
47. Fredd, S. (1995). Standards of approval of new drugs for IBD. Inflammatory Bowel Diseases 1, 284-94. Received 10 September 1996; returned 21 October 1996; revised 7 November 1996; accepted 12 December 1996